Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Surgical periodontal therapy for the management of intrabony/furcation defects with and without topically delivered Alendronate - a systematic review and meta-analysis

Abstract

Objective

Alendronate (ALN) are pyrophosphates which prevent bone resorption and aid in periodontal regeneration. The present review aimed to evaluate the success of surgical periodontal therapy in the management of intrabony/ furcation defects with and without topical application of ALN.

Method

Using combinations of different search terms, the authors searched the standard electronic databases for randomised controlled trials. Version 2 of the Cochrane risk of bias tool for randomised trials was used for quality appraisal. The random-effects model was used for the statistical analysis of estimated effect sizes. The overall quality of evidence was assessed using GRADEpro GDT software.

Results

Nine studies satisfying all inclusion criteria were selected for qualitative analysis, and six studies with homogeneous data were selected for quantitative analysis. The overall risk of bias had “low” concerns in one study, “some” concerns in four studies, and “high” concerns in four studies. The pooled analysis showed that the experimental group showed a significant reduction in periodontal probing depth(PPD) and defect depth(DD) with a standard mean difference(SDM) of 1.06 mm (95% CI, 0.77–1.34; P < 0.00001; I2 = 0%) and 1.10 mm (95% CI, 0.65–1.54; P < 0.00001; I2 = 56%) respectively, significant improvement in the clinical attachment level (CAL) with SDM of 1.03 mm (95% CI, 0.42-1.64; P = 0.0009; I2 = 76%).

Conclusions

The topical application of ALN has been shown to enhance the effectiveness of surgical periodontal therapy by reducing the PPD and DD and increasing the CAL; however, the certainty of evidence remains very low to low.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data supporting this article can be made available by the corresponding author upon request.

References

  1. Kwon TH, Lamster IB, Levin L. Current Concepts in the Management of Periodontitis. Int Dent J. 2021;71:462–76. https://doi.org/10.1111/IDJ.12630.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Jepsen K, Sculean A, Jepsen S. Complications and treatment errors related to regenerative periodontal surgery. Periodontol 2000. 2023;92:120–34. https://doi.org/10.1111/PRD.12504.

    Article  PubMed  Google Scholar 

  3. Reynolds MA, Kao RT, Camargo PM, Caton JG, Clem DS, Fiorellini JP, et al. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop. J Periodontol. 2015;86. https://doi.org/10.1902/JOP.2015.140378.

  4. Lin Z, Rios HF, Cochran DL Emerging regenerative approaches for periodontal reconstruction: a systematic review from the AAP Regeneration Workshop. J Periodontol. 2015;86. https://doi.org/10.1902/JOP.2015.130689.

  5. Liang Y, Luan X, Liu X. Recent advances in periodontal regeneration: A biomaterial perspective. Bioact Mater. 2020;5:297–308. https://doi.org/10.1016/J.BIOACTMAT.2020.02.012.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kwoen MJ, Park JH, Kim KS, Lee JR, Kim JW, Lee H, et al. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study. J Periodontol. 2023;94:98–107. https://doi.org/10.1002/JPER.21-0611.

    Article  CAS  PubMed  Google Scholar 

  7. Alwithanani N. Role of bisphosphonates in periodontal diseases: systematic review. J Pharm Bioallied Sci. 2023;15:S46–S53. https://doi.org/10.4103/JPBS.JPBS_504_22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Veena H, Prasad D. Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects. J Indian Soc Periodontol. 2010;14:40 https://doi.org/10.4103/0972-124X.65438.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gupta J, Gill AS, Sikri P. Evaluation of the relative efficacy of an alloplast used alone and in conjunction with an osteoclast inhibitor in the treatment of human periodontal infrabony defects: a clinical and radiological study. Indian J Dent Res. 2011;22:225–31. https://doi.org/10.4103/0970-9290.84292.

    Article  PubMed  Google Scholar 

  10. Carvalho Dutra B, Oliveira AMSD, Oliveira PAD, Miranda Cota LO, Silveira JO, Costa FO. Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: A 6-month randomized controlled clinical trial. J Periodontol. 2019;90:1079–87. https://doi.org/10.1002/JPER.19-0160.

    Article  CAS  PubMed  Google Scholar 

  11. Kanoriya D, Pradeep AR, Singhal S, Garg V, Guruprasad CN. Synergistic approach using platelet-rich fibrin and 1% alendronate for intrabony defect treatment in chronic periodontitis: a randomized clinical trial. J Periodontol. 2016;87:1427–35. https://doi.org/10.1902/JOP.2016.150698.

    Article  CAS  PubMed  Google Scholar 

  12. Naineni R, Ravi V, Subbaraya DK, Prasanna JS, Panthula VR, Koduganti RR. Effect of alendronate with β - TCP bone substitute in surgical therapy of periodontal intra-osseous defects: a randomized controlled clinical trial. J Clin Diagn Res. 2016;10:ZC113–ZC117. https://doi.org/10.7860/JCDR/2016/20965.8365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https://doi.org/10.1136/BMJ.N71.

  14. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343. https://doi.org/10.1136/BMJ.D5928.

  15. Zhang Y, Akl EA, Schünemann HJ. Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods. 2018;10:312–29. https://doi.org/10.1002/JRSM.1313.

    Article  Google Scholar 

  16. McMaster University. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. Evidence Prime, Inc. Published online (2015).

  17. Wanikar I, Rathod S, Kolte AP. Clinico-radiographic evaluation of 1% alendronate gel as an adjunct and smart blood derivative platelet rich fibrin in grade II furcation defects. J Periodontol. 2019;90:52–60. https://doi.org/10.1002/JPER.18-0146.

    Article  CAS  PubMed  Google Scholar 

  18. Kanoriya D, Pradeep AR, Garg V, Singhal S. Mandibular Degree II furcation defects treatment with platelet-rich fibrin and 1% Alendronate gel combination: a randomized controlled clinical trial. J Periodontol. 2017;88:250–8. https://doi.org/10.1902/JOP.2016.160269.

    Article  CAS  PubMed  Google Scholar 

  19. Selvalakshmi Saravanan G, Kumar NT, Kumar RSRVRJM. Effect of bone graft and platelet rich fibrin with and without alendronate in the management of intrabony periodontal defect – a randomized clinical study. J Chem Health Risks. 2024;14:287–96. https://doi.org/10.52783/JCHR.V14.I5.6109.

    Article  Google Scholar 

  20. Mat AL-khaiyat SS, HR, Abdulbaqi MT. Mandibular Degree II Furcation Defect Treatment With 1% Alendronate Gel Alone or In Combination with Platelet-Rich Fibrin. J Pharmaceut Sci Res. 2019;11:1856–60. https://www.researchgate.net/profile/Saif-Saliem/publication/339091576_Mandibular_Degree_II_Furcation_Defect_Treatment_With_1Alendronate_Gel_Alone_or_In_Combination_with_Platelet-_Rich_Fibrin/links/5e3d5188299bf1cdb9151708/Mandibular-Degree-II-Furcation-Defect-Treatment-With-1Alendronate-Gel-Alone-or-In-Combination-with-Platelet-Rich-Fibrin.pdf Accessed November 16, 2024.

    Google Scholar 

  21. Kitasato S, Tanaka T, Chazono M, Komaki H, Kakuta A, Inagaki N, et al. Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2. J Biomed Mater Res A. 2020;108:528–36. https://doi.org/10.1002/JBM.A.36833.

    Article  CAS  PubMed  Google Scholar 

  22. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:834–40. https://doi.org/10.1016/J.JCLINEPI.2010.02.005.

    Article  PubMed  Google Scholar 

  23. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011;64:1283–93. https://doi.org/10.1016/J.JCLINEPI.2011.01.012.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Pravin Kumar formulated the concept and design. Arun Kumar Patnana and A Rizwan Ali conducted literature search, data extraction from the included articles. Pravin Kumar, Arun Kumar Patnana, A Rizwan Ali and Karishma Pathak were involved in the analysis and interpretation of the data. Pravin Kumar, Arun Kumar Patnana, Ankita Chugh and Kirti Chaudhry drafted the manuscript. Pravin Kumar critically revised the manuscript and approved the final version to be published.

Corresponding author

Correspondence to A. Rizwan Ali.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, A.R., Patnana, A.K., Kumar, P. et al. Surgical periodontal therapy for the management of intrabony/furcation defects with and without topically delivered Alendronate - a systematic review and meta-analysis. Evid Based Dent 26, 156–157 (2025). https://doi.org/10.1038/s41432-025-01165-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41432-025-01165-0

Search

Quick links